Short Glenn Frank 4
4 · ATAI Life Sciences N.V. · Filed Mar 24, 2025
Insider Transaction Report
Form 4
Short Glenn Frank
Chief Scientific Officer
Transactions
- Sale
Common Shares
2025-03-21$1.35/sh−13,161$17,767→ 42,333 total
Footnotes (1)
- [F1]Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.